Natalie Sacks, Chief Medical Officer at Harpoon Therapeutics, Inc. (HARP), sold 1,521 shares at $17.02 ($26K) on 2019-12-16, disclosed to the SEC on 2019-12-18.
Scheduled sale ($26k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| HARP | SELL | 2020-04-17 | $18K | — | Filing → |
| HARP | SELL | 2020-04-15 | $110K | — | Filing → |
| HARP | SELL | 2020-04-08 | $15K | — | Filing → |